On September 1, 2022 Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, reported that management will present at the 2022 Wells Fargo Healthcare Conference, taking place September 7-9, 2022, in Boston, MA, and participate in a fireside chat at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022, in New York, NY (Press release, Gritstone Oncology, SEP 1, 2022, View Source [SID1234618879]). The events will also be available via webcast. Please find additional details about the events below.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2022 Wells Fargo Healthcare Conference
Presentation Date: Thursday, September 8, 2022, 1:20pm EDT
Presenters: Celia Economides, Chief Financial Officer and Matthew J. Hawryluk, Chief Business Officer
Location: Boston, MA
Webcast: View Source

H.C. Wainwright 24th Annual Global Investment Conference
Fireside Chat Date: Tuesday, September 13, 2022, 3:30pm EDT
Participant: Andrew Allen, M.D., Ph.D., Co-founder, President and Chief Executive Officer
Location: New York, NY
Webcast: View Source

The events will be accessible via the Investors & Media section of the company’s website at View Source Archived replays will be accessible for 30 days following the events.